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\s=b\Because the prevalence of idiopathic Parkinson's disease(PD) with or without dementia remains controversial, we
initiated a population-based investigation in the Washing-
ton Heights\p=m-\Inwoodsection of New York, NY, so that
nearly complete case ascertainment could be achieved. A
"registry" was developed for the study, and we advertised
in periodicals and on radio and television. Subjects, or their
records, were examined by experienced neurologists, and
most underwent a battery of neuropsychological tests spe-
cifically designed for assessment in this community. All data
were reviewed by a team of clinicians to achieve a consen-
sus diagnosis. The crude prevalence of idiopathic PD, with
and without dementia, was 99.4 per 100 000, increasing
from 2.3 per 100 000 for those younger than 50 years to
1144.9 per 100 000 for those aged 80 years and older. The
crude prevalence for PD with dementia alone was 41.1 per
100 000 and also increased with age from zero for those
younger than 50 years to 787.1 per 100 000 for those aged
80 years and older. Prevalence ratios were comparable with
those of other published population-based studies in simi-
lar settings. After standardization, men had PD with and
without dementia more frequently than did women. The
major difference between patients with and without de-
mentia was a later estimated age at onset of motor manifes-
tations. We conclude that PD is a frequent disorder in the
elderly population that affects men and whites more
frequently than women and nonwhites. Moreover, demen-
tia in patients with PD is more frequent than previously
recognized and is strongly related to the age at onset of
motor manifestations.
(Arch Neurol. 1992;49:492-497)
The prevalence of idiopathic Parkinson's disease (PD)has been estimated to be between 80.61 and 187.02
per 100000 in the general population. The age-specific
prevalence ratio increases dramatically with age. For ex-
ample, in patients older than 65 years, the prevalence of
PD is twice that for all lower age groups combined and
doubles again after age 75 years.3 At age 65 years and
older, the prevalence of PD varies from 350 to 800 per
100000. Both gender and racial differences have been re¬ported,4·5 but they are not consistent.6 Some degree of
variation in reports of prevalence may be due to an
imprecise definition of idiopathic PD, resulting in the in¬
clusion of patients with secondary parkinsonism.
The frequency of dementia in patients with idiopathic
PD is also controversial. It is significantly more frequent in
older patients,7"13 particularly when motor manifestations
begin after age 70 years.9 Marttila and Rinne10 and oth¬
ers1112 report the frequency of dementia in patients with
PD to be 30%. However, Brown and Marsden13 believe the
frequency of dementia to be overestimated because of the
lack of specific criteria for the diagnosis of dementia.
To overcome some of the méthodologie issues of previous
studies, we began a population-based study of PD and PD
with dementia in the community of Washington Heights-
Inwood in the northern part of the borough of Manhattan in
New York, NY. We attempted complete case ascertainment
in the region called Community District 12 (CD12), where,
according to the 1980 census, 179 941 people reside, includ¬
ing nearly 35 000 elderly people (defined as persons older
than 60 years). We used strict criteria for the diagnosis of id¬
iopathic PD and for the diagnosis of dementia. Our objective
was to estimate the population prevalence of PD with and
without dementia in this geographically limited and cultur¬
ally diverse area of northern Manhattan.
SUBJECTS AND METHODS
Subject Selection
To be included as a subject, all patients must have lived within
the four zip codes identified as CD12 in Washington Heights-
Inwood during the period of recruitment, which was from April
1, 1988, to December 31, 1990. Subjects were identified through
the development of a "registry" for PD in the community for all
individuals considered to have PD or a related disorder. This reg¬
istry for PD included all patients seen at the Columbia Presby¬
terian Medical Center who resided in the community. Patients
were identified from a series of sources: admission and discharge
lists from the hospital, lists from various ambulatory care sites,
contact with practitioners both in the hospital and in the commu¬
nity, and review of their charts. The International Classification of
Diseases, Ninth Revision codes on computer-generated billing lists
from various medical sources and registries of inpatients and out¬
patients at local medical centers were also used to identify sub¬jects. Announcements were placed in every local newspaper for
a 2V2-year period around the time of the study. Both television
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and radio programs carried public announcements about the
study during the same period. Private practitioners and the single
neurologist in the community of Washington Heights-Inwood
who is not affiliated with the medical center were also personally
contacted. We were also given access to medical record informa¬
tion from the regional Health Insurance Providers in the upper
part of Manhattan. A list of individuals with home health atten¬
dants was also obtained from the Health Resources Association
and reviewed to identify patients with PD.
Using names and existing telephone numbers, subjects were
contacted and asked to participate. Only those subjects able to
give informed consent or who had a next of kin willing to grant
informed consent on his or her behalf were fully examined in the
course of our investigation.
Some individuals were identified through the registry but
could not be examined for a number of reasons. The medical
records of these individuals were reviewed by a neurologist(R.M.) to obtain appropriate clinical information. For the pur¬
pose of our investigation, we required that these patients have
documented evidence in the record of having been examined
during the prevalence period and that they meet the same inclu¬
sion and exclusion criteria for PD as the patients who were ex¬
amined. When no information was found, the patient was con¬
tacted at the last known address or telephone number. Patients
were considered "missing" when no information was available.
Inclusion Criteria
Idiopathic PD was defined as the primary form of the disease
in which review of the medical history and physical signs indi¬
cated no other disease process that could be considered the cause
of the disorder. Two of the following four cardinal features of PD
must have been present on clinical examination or mentioned in
the medical records: resting tremor, shuffling gait, bradykinesia,
or muscular rigidity.
Exclusion Criteria
Patients were excluded if they had any of the following disor¬
ders: secondary or symptomatic parkinsonism (postencepha-litic) or parkinsonism resulting from any of the following drugs:
phenothiazines, alphamethyldopa, reserpine, or metaclopra-
mide hydrochloride. Patients with progressive supranuclear
palsy, essential tremor, Shy-Drager syndrome, presumed stria-
tonigral degeneration, and olivopontocerebellar degeneration
were also excluded, as were patients who developed memory
loss or dementia before motor manifestations of PD and any pa¬
tient considered to have the "extrapyramidal form" of Alz¬
heimer's disease.14
Demographic Data
Information regarding current age, date of birth, location of
birth, residence since birth, occupation, and duration of formal
education was obtained in the initial interview or record review.
For ethnic group assignment, the US Census Bureau format was
used; a similar process is used by the hospital record system.
Subjects were asked to which ethnic group they belonged and
were given choices. We attempted to subdivide Hispanic pa¬
tients into country of origin. (The questionnaire used is available
from the authors upon request.)
Clinical Evaluation
Patients underwent a neurologic examination by one of three
experienced neurologists (L.J.C., K.M., or R.M.). The presence
and severity of motor signs and symptoms were recorded by the
physician using the Unified Parkinson's Disease Rating Scale.15
Current medications were listed in a semistructured format by
a trained interviewer, as was the history of the current illness.
If the patient was unable to give a history or appeared to be de¬
mented, the interview was conducted with the next of kin. In¬
formation regarding performance of activities of daily living was
obtained during the same interview with part 1 of the Blessed
Dementia Rating Scale16 and the Schwab and England17 rating
scale of activities of daily living. All interviews were conducted
in either Spanish or English, according to the patient's choice.
All patients underwent a complete neuropsychological assess¬
ment (also conducted in either Spanish or English, according to
the patient's choice), which included the following tests: (1) ori¬
entation from the Modified Mini-Mental State Examination18; (2)
the Selective Reminding Test19; (3) a multiple-choice version of
the Benton Visual Retention Test (matching and recognition)20;(4) five selected items from the Rosen Drawing Test21; (5) 15 items
from the Boston Naming Test22; (6) the Controlled Oral Word As¬
sociation Test23 and the Animal Naming24 test; (7) selected items
from the Comprehension and Repetition subtests from the Bos¬
ton Diagnostic Aphasia Examination24; (8) the Similarities subtest
from the Wechsler Adult Intelligence Scale-Revised25; and (9)
Identities and Oddities from the Mattis Dementia Rating Scale.26
These neuropsychological tests were scored and compared
with a series of cutoff scores developed in a pilot study of
dementia in the community. The cutoff scores and their appli¬
cation to diagnosis have been described previously.27 Briefly,
demonstrable impairment in memory, and a similar degree of
impairment in at least two other cognitive categories, including
abstract thinking, constructional ability, language, and orienta¬
tion, was required for a patient to meet criteria for dementia.28
The impairment could not have resulted from delirium or an al¬
teration in consciousness.
The evaluation of social or occupational function, also required
for the diagnosis of dementia,28 was made with use of the Activ¬
ities of Daily Living measures and medical history. We separated
functional impairment due to intellectual dysfunction from that
due to physical impairment. At the consensus conference, all the
information derived from the neurologic examination and that
derived from neuropsychological assessment were reviewed by
a group of physicians and neuropsychologists, some of whom
were involved in the assessment of the patient. For all dementia
diagnoses, a consensus among the reviewers was required.
The diagnosis of idiopathic PD and dementia in the 22 patients
not examined was made from a review of the records. For the
diagnosis of idiopathic PD, we used the same inclusion and ex¬
clusion criteria. However, we required the diagnosis to have
been made and entered into the medical records by the attend¬
ing physician. In every case, this attending physician was a
neurologist. For dementia, we required written evidence in the
records of a history of intellectual impairment, verified by a
neurologic examination or neuropsychological tests. For both
diagnoses, we required that they had not been retracted or
changed in subsequent entries in the medical record.
Database Management and Statistical Analysis
All data were entered by the data entry clerk and periodically
checked by the project coordinators. Data were stored with the
use of the Scientific Information Retrieval database management
software. Analytic methods consisted primarily of calculations of
rates and proportions.29,30 To compare the prevalence of idio¬
pathic PD between men and women and among ethnic groups,
as well as to compare our data with those of other studies, in¬
direct standardization was used.30 We calculated standardized
prevalence rates by weighting each age group based on the pro¬
portion of the age group in the total population according to the
1988 US Department of Commerce Bureau of Census estimates.31
Each comparison between gender, ethnicity, or studies was ex¬
pressed as a standardized rate ratio, defined as the ratio of the
standardized prevalence rate in one group to that in another.
RESULTS
Parkinson's Disease
A total of 258 cases of presumed parkinsonism were
identified by the registry, from which we determined that
179 cases (71%) were the idiopathic form of PD. The flow
diagram shown in the Figure traces patient ascertainment.
A total of 166 patients (64%) were examined by one of us
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to verify diagnosis, but only 157 were found to have id¬
iopathic PD. The other nine patients were deemed to have
secondary forms of parkinsonism. Among the 92 cases
that were limited to record review, we identified 49 pa¬
tients meeting inclusion criteria. The remaining 43 pa¬
tients had either secondary parkinsonism (n = 15) or other
disorders (n = 22); in six patients, no clinical information
was available to determine diagnosis. Among the 49 eli¬
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alence period; four others were known by us to be cases,
but no information was available, and 23 were not seen af¬
ter April 1, 1988. Thus, the total number of valid cases for
this study identified by the two methods was 179 (157 ex¬
amined cases and 22 records reviewed). The remaining
analyses and discussion are based only on information de¬
rived from this group of patients with idiopathic PD. Their
demographic characteristics are summarized in Table 1.
A total of 41.3% of these patients were found to havedementia during the prevalence period. Table 1 shows the
demographic characteristics of the patients with and
without dementia.
According to the 1980 census, 179 941 people resided in
northern Manhattan. The total number of individuals in
this community did not change significantly by the 1990
census, remaining within 3% of the 1980 figures. The
crude prevalence of PD as of the midpoint date (July 1,
1989) was 99.48 per 100 000 persons. For the group 35
years and older, the crude prevalence was 219.8 per
100000. The age-specific prevalence increased dramati¬
cally with age from 2.3 per 100 000 for those younger than
50 years to 1144.9 per 100 000 for those older than 80 years(Table 2). The proportion of those with dementia is pre¬
sented in Table 2.
The age-specific prevalence in the community was stan¬dardized to the 1988 US census estimates.31 There were
191.2 cases per 100 000 in the population aged 35 years and
older and 86.9 cases per 100 000 for all age groups. For com¬
parison, the standardized age-specific prevalence is
shown in Table 3 for two similar studies—one in North-
hampton, England,32 and the other in Copiati County,
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*Data include all patients examined and those from record review. Washington Heights-Inwood is a community in Manhattan, NY.
tP<.001.
Table 2. —Prevalence of Parkinson's Disease (PD): Crude Ratios of Patients With and
Without Dementia in Washington Heights-Inwood*
Crude Prevalencet
I I
Age Group, y PD Total PD With Dementia Proportion Demented Population Base (1980)
<50 23(3) 0(0) 0 128148
50-59 45.7 (8) 5.7 (1) 0.124 17468
60-69 234.8(38) 55.6(9) 0.236 16179
70-79 525.6 (66) 159.2 (20) 0.302 12556
>80 1144.9 (64) 787.1 (44) 0.687 5590
All ages 99.4 41.1(74) 0.413 179941
'Washington Heights-Inwood is a community in Manhattan, NY.
tValues are per 100000. Numbers in parentheses indicate numbers of patients.
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Mississippi.6 Standardized rate ratios were calculated for
the comparisons between these two studies and ours (Ta¬
ble 3). As is apparent, the standardized age-specific prev¬
alences differ primarily in the younger patients.
We also calculated crude prevalence ratios for different
ethnic groups in the Washington Heights-Inwood sam¬
ple. We assumed that there might be an increase in the
number of Hispanic residents relative to white and black
residents due to shifts in the proportions of the popula¬
tion during the 1980s. Therefore, the 1980 census data
with regard to ethnic groups would underestimate the
Hispanic population in the community and overestimate
the white population. Because 1990 census data were not
available for these comparisons, we corrected for this by
estimating the current ratio of the three ethnic groups in
the community from data available to us through Medi¬
care registration in 1989 and through our own survey of
more than 2500 subjects participating in a community-based study of neurologic disorders. Based on data from
these sources, of individuals older than 60 years, 35.3%
were black, 37.4% were Hispanic, and 21.3% were white.
The overall crude prevalence ratios for blacks was 107.3
per 100000, for Hispanics was 521.6 per 100000, and for
whites was 1176.8 per 100000. We did not standardize
these estimates because of the uncertainty of the denom-
inator information. Therefore, any comparison between
ethnic groups at this time would be misleading. We an¬
ticipate age-specific denominator information by ethnic
group to be available in the spring of 1992.
The comparison of prevalence in men and women in¬dicated a 73% increase in the standardized prevalence for
PD with and without dementia for men in nearly every
age group. There was an 87% increase in the standardized
prevalence of PD with dementia in men (Table 4).
Parkinson's Disease With Dementia
The overall crude prevalence of PD with dementia was
41.1 per 100000, and the crude prevalence for those indi¬
viduals older than 35 years was 90.8 per 100 000 (Table 2).
The age-specific prevalence of PD with dementia also in¬
creased with age, parallel to the increase in PD overall, as
noted in Table 2, from zero per 100 000 for those younger
than 50 years to 787.1 per 100 000 older than 80 years. The
standardized prevalence ranged from 5.3 per 100000 for
those between ages 35 and 64 years to 62.5 per 100 000 for
those older than 75 years (Table 5). The standardized rate
ratio for dementia was 0.39 overall, as noted in Table 5.
Demented patients were older than their nondemented
peers, but duration of motor manifestations was identical(Table 1). To compare the prevalence of PD with demon-
Table 3.—Comparison of Standardized, Age-Specific Prevalence Ratio of Parkinson's Disease in New York,Mississippi, and the United Kingdom*
Washington Mississippi and Standardized
Age Group, y Heights-lnwoodt United Kingdom Rate Ratio
Copiah County, Miss (6)
40-64 39.8 93.0 0.43
65-74 43.2 87.9 0.49
75+ 106.8 105.3 1.01
Total_191.2 _286.3 _0.66
Northhampton, UK (32)
<50 1.7 2.2 0.78
50-59 4.1 8.2 0.50
60-69 20.1 24.4 0.83
70-79 29.9 47.9 0.62
>80 30.9 34.9 0.88
Total 86.9 117.8 0.78
*Data are standardized to the US census estimate for 1988 (US Department of Commerce31).
tWashington Heights-Inwood is a community in Manhattan, NY.
*Data are per 100 000.
Table 4.—Comparison of Standardized Prevalence Ratio for Parkinson's Disease (PD)With and Without Dementia by Gender
PD in Women*
 Data are per 100 000.
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Table 5.—Standardized Rate Ratio of Dementia












*Data are based on US census estimates for 1988. Washington
Heights-Inwood is a community in Manhattan, NY.
tData are per 100 000.
tPDD indicates PD with dementia.
tia with that of clinically diagnosed Alzheimer's disease,
we used the age-specific prevalence ratios from the East¬
ern Baltimore Mental Health Survey.33 We found a stan¬
dardized rate of clinically diagnosed Alzheimer's disease
in that study to be 550 per 100000 compared with the
standardized rate of PD with dementia in our study of
70.7 per 100000.
COMMENT
We found that the age-specific prevalence ratio of PD in¬
creases dramatically with age, as has been reported by other
investigators.1"3·6,32 Furthermore, we believe our study to be
one of the few population-based estimates of dementia in pa¬
tients with PD. The overall frequency of dementia was
41.3%, much higher than expected based on earlier
studies.7"13 The proportion of patients with dementia also in¬
creased with age, as did the age-specific prevalence of PD
with dementia. However, the standardized rate ratio for clin¬
ically diagnosed Alzheimer's disease was still nearly eight
times that for PD with dementia in our investigation.
We confirmed the increased prevalence of PD in men
relative to women and found a similar relationship for PD
with dementia. Our data regarding the prevalence of PD
in each ethnic group suggests that whites are more
frequently affected than are either blacks or Hispanics,
but this was based on estimates of the distribution of each
ethnic group and requires confirmation when appropriatedata are available from the 1990 census. Moreover, any
differences in prevalence should be confirmed with inci¬
dence data to reduce "prevalent case bias."31 As with any
prevalence or cross-sectional investigation, our collecteddata should be interpreted with caution.
How Complete Was Case Ascertainment in the
Washington Heights-Inwood Community?
Because the community is a relatively small geographic
area with a single hospital in the region, we believe that the
sample represents a nearly complete sample. Our estimate
may be lower than that in Copiah County6 and Northhamp-
ton32 because we used very strict criteria for the diagnosis of
PD. Still, our estimate of prevalence was similar to those of
studies that used different methods of case ascertain¬
ment. ''6'32 During the course of our study, we were fortunate
to have access to a survey of 700 elderly (older than 65 years)
members of our target community who were receiving home
assistance from the Health Resources Association. Of the 28
cases of PD identified in that survey, only three patients were
previously unknown to us. This suggests that our case-
ascertainment in that particular region of the community
was as complete as was possible in an urban area. We also
reviewed cHnic records from the adjacent community of
Harlem and found only two eligible cases for our study.
Our estimate of the prevalence of PD was somewhat
lower than expected based on published rates in the
studies from Northhampton32 and Copiah County,6 ex¬
cept in the older age groups. This may reflect differences
in methods of recruitment as well as our stricter criteria for
the diagnosis of PD.
We observed fewer cases of PD among Hispanics and
blacks than among whites. The prevalence ratios may
"artificially" differ among the three ethnic groups because
of the apparent change in the proportions each group
represents in the current population.
Was There a Selection Bias in the Identification of Cases?
We cannot identify a systematic bias in the identifica¬
tion of cases in our study. Patients were identified during
a 21/2-year period. It is possible that patients with more
advanced illness were more easily identified by the
methods we used, which would have increased the num¬
ber of patients with dementia. However, we have no in¬dication that this occurred, because all cases were identi¬
fied with similar methods of surveillance.
Was the Definition of Parkinson's Disease and Dementia
Adequate and Appropriate?
According to Rajput et al,34 the accuracy of a clinical di¬
agnosis of PD may be as low as 76%, which would make
epidemiologie studies difficult. Rajput et al also noted that
this figure improved when patients were followed up for
a period of 5 years or more34 and when multiple examiners
were used. By requiring two defining features, we were
assured of the identification of "typical" cases, although
we may have missed subtle or very mild cases of idiopathic
PD. We believe that we were able to exclude essential
tremor and secondary forms of parkinsonism, which may
also explain why our overall prevalence was lower than
that in the other two studies cited, because their criteria
were not as strict. When the diagnosis was in question, the
other neurologists participating in the study were asked to
examine the patient, and a consensus was reached.
The diagnosis of dementia is difficult in our community
because the educational level varies considerably, and edu¬
cational level may affect performance on neuropsychological
tests. We used a two-stage approach to the diagnosis. First,
the neurologist made a decision based on the medical his¬
tory, the ability to perform activities of daily living, the results
of a neurologic examination, and a brief assessment of men¬
tal status. Second, the neuropsychological testing was per¬
formed on the same date but independently. The battery of
neuropsychological tests had been developed and tested in
the community before its application in this project.27 All in¬
formation derived from these interviews was used in a con¬
sensus conference attended by all investigators to determine
the final diagnosis. To reduce education bias, our diagnostic
criteria for dementia required that a patient exhibit impair¬
ment in performing the activities of daily living that were di¬
rectly related to cognitive decline. A patient who performed
poorly on neuropsychological tests but was able to function
independently was not considered to be demented. Thus,
while we may not have fully eliminated bias in diagnoses
with regard to dementia, we believe that we reduced bias to
a minimum.
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How Common Is Dementia in Parkinson's Disease?
In 1984, Brown and Marsden13 challenged colleagues by
positing that the frequency of dementia in the majority of
studies published at that time had been overestimated.
They found inconsistencies in the criteria for the diagno¬
sis of PD and dementia and identified a number of poten¬
tial problems that could obscure the diagnosis of demen¬
tia in PD. Their review of investigations performed during
the last 60 years indicated an estimate of between 35% and
90%, but they intimated that when Diagnostic and Statis¬
tical Manual of Mental Disorders, Revised Third Edition crite¬
ria28 for dementia were applied, a lower estimate of 15%
would better reflect the actual frequency of dementia.
Their report was supported by subsequent studies.35-36
Strict criteria for PD and for dementia would improve
the accuracy of estimates of their frequency. In addition,
unless the population from which patients are selected is
specified, prevalence estimates might simply reflect a se¬
lection bias from a particular hospital or clinic. In the sin¬
gle community-based study, Sutcliffe32 found an 11%
prevalence rate for dementia in PD in Northhampton but
failed to use precise diagnostic criteria.
Rajput et al3 found the cumulative probability of pa¬
tients with PD developing dementia to be 21.1% com¬
pared with 5.7% for the healthy controls in a retrospective
chart review. In our own clinic- and hospital-based
investigation,9-37 the cumulative risk of dementia in pa¬
tients with idiopathic PD was 60% by age 85 years. These
investigations need to be confirmed in "population-
based" prospective studies.
Parkinson's disease is a common degenerative disease
of the nervous system. Our study indicates that it is more
frequent in the elderly and progresses dramatically with
increasing age. We also found the expected differences in
gender and evidence for differences in prevalence in the
black and Hispanic populations.
With regard to dementia, we report the first population
prevalence ratio for dementia in patients with idiopathic
PD: 41.3%. We also confirm earlier work that indicates that
PD with dementia is clearly age dependent, and its fre¬
quency increases with each decade of life. The prevalent
cases with and without dementia differed in age but not
duration of illness (motor manifestations). This strongly
suggests that age at onset of PD influences the prevalence
of dementia. Confirmation of these data awaits studies of
incidence rates of PD with and without dementia.
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